可切除非小细胞肺癌循环与肿瘤髓源性抑制细胞研究
该前瞻性研究采用流式细胞术和Bio-Plex法分析可切除非小细胞肺癌患者肿瘤与外周血中髓源性抑制细胞(MDSC)亚群及炎症因子。发现循环单核细胞型MDSC频率较健康供者显著升高,肿瘤内MDSC频率高于外周血,且循环PMN-MDSC和CCR5+ M-MDSC频率与无复发生存期负相关,提示外周血MDSC水平可预测术后复发。
要点
- 非小细胞肺癌患者循环M-MDSC频率显著高于健康供者
- 肿瘤内M-MDSC和PMN-MDSC频率高于同一患者外周血
- 循环PMN-MDSC和CCR5+ M-MDSC频率与无复发生存期负相关
核心结论
- 外周血而非肿瘤组织中的MDSC水平可预测可切除非小细胞肺癌术后复发。
研究设计与样本
- 前瞻性研究,对可切除非小细胞肺癌患者的肿瘤和外周血样本进行MDSC亚群及炎症因子复杂分析。
- 采用流式细胞术和Bio-Plex法检测,并与健康供者比较。
主要发现
- 非小细胞肺癌患者循环M-MDSC频率较健康供者显著增加。
- 同一患者肿瘤中M-MDSC和PMN-MDSC频率高于外周血。
- MDSC积累与肿瘤微环境中参与MDSC迁移和激活的炎症介质浓度升高相关。
- 患者循环细胞程序性死亡配体1(PD-L1)表达较健康供者增加,肿瘤PMN-MDSC的PD-L1表达高于外周血同名细胞。
- 患者循环M-MDSC上CCR5表达频率显著高于健康供者。
关键数值与推荐
- 无复发生存期与循环中PMN-MDSC频率呈负相关。
- 无复发生存期与循环中CCR5+ M-MDSC频率呈负相关。
- 无复发生存期与肿瘤中PMN-MDSC或CCR5+ M-MDSC频率无显著相关性。
临床怎么用
- 可考虑检测外周血MDSC亚群(尤其PMN-MDSC和CCR5+ M-MDSC)辅助评估可切除非小细胞肺癌术后复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Myeloid-derived suppressor cell (MDSC) expansion has been found to play a role in disease progression in patients with cancer. However, the characteristics of MDSCs in lung cancer are poorly understood. OBJECTIVES: We prospectively investigated MDSCs and inflammatory factors in tumor and peripheral blood samples from patients with resectable non-small cell lung cancer and studied their correlations with the disease prognosis. METHODS: A complex analysis of MDSC subsets and inflammatory mediators was performed using flow cytometry and a Bio-Plex assay. MEASUREMENTS AND MAIN RESULTS: A significant increase in the frequency of circulating monocytic (M)-MDSCs was observed in the patients with non-small cell lung cancer compared with the healthy donors (HDs). Moreover, the frequencies of M- and polymorphonuclear (PMN)-MDSCs were higher in tumors than in the peripheral blood of the same patients. This accumulation was associated with elevated concentrations of inflammatory mediators involved in MDSC migration to and activation in the tumor microenvironment. An analysis of the MDSC immunosuppressive pattern showed increased programmed death-ligand 1 expression on circulating cells from patients compared with HDs. Tumor PMN-MDSCs displayed higher programmed death-ligand 1 expression levels than the same cells in the peripheral blood. The frequency of CCR5 (C-C chemokine receptor 5) expression on circulating M-MDSCs was significantly higher in the patients than in the HDs. Clinical data analysis revealed negative correlations between recurrence-free survival and the frequencies of PMN-MDSCs and CCR5+ M-MDSCs in the circulation but not in tumors. CONCLUSIONS: Our findings suggest that the level of MDSCs in the peripheral blood but not in tumor tissues predicts recurrence after surgery.
引用
- Yamauchi Y, Safi S, Blattner C, et al. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer. Am J Respir Crit Care Med. 2018. PMID: 29617574. doi:10.1164/rccm.201708-1707OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。